Zobrazeno 1 - 10
of 53
pro vyhledávání: '"Fagerli, UM"'
Autor:
D'Amore, Francesco Annibale, Relander, T, Lauritzsen, GF, Jantunen, E, Hagberg, H, Anderson, H, Holte, H, Østerborg, A, Merup, M, Brown, Peter De Nully, Østenstad, B, Kuittinen, O, Erlanson, M, Fagerli, UM, Gadeberg, O, Sundström, C, Delabie, J, Ralfkiaer, E, Vornanen, M, Toldbod, H
Publikováno v:
D'Amore, F A, Relander, T, Lauritzsen, GF, Jantunen, E, Hagberg, H, Anderson, H, Holte, H, Østerborg, A, Merup, M, Brown, P D N, Østenstad, B, Kuittinen, O, Erlanson, M, Fagerli, UM, Gadeberg, O, Sundström, C, Delabie, J, Ralfkiaer, E, Vornanen, M & Toldbod, H 2012, ' High-dose chemotherapy and autologous stem cell transplantation in previously untreated peripheral T-cell lymphoma-final analysis of a large prospective multicenter study (NLG-T-01) ', Blood, vol. 118, pp. 331 .
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pure_au_____::dfcabb84673ba0800b197b48699cd7bf
https://pure.au.dk/portal/da/publications/highdose-chemotherapy-and-autologous-stem-cell-transplantation-in-previously-untreated-peripheral-tcell-lymphoma--final-analysis-of-a-large-prospective-multicenter-study-nlgt01(c33212dc-1b07-43ca-9e26-8f3348f96e5a).html
https://pure.au.dk/portal/da/publications/highdose-chemotherapy-and-autologous-stem-cell-transplantation-in-previously-untreated-peripheral-tcell-lymphoma--final-analysis-of-a-large-prospective-multicenter-study-nlgt01(c33212dc-1b07-43ca-9e26-8f3348f96e5a).html
Autor:
D'Amore, Francesco Annibale, Gomes da Silva, M, Leppa, S, Relander, T, Pezzutto, A, Lauritzsen, GF, Weidmann, E, Van Gelder, M, Merup, M, Hagberg, H, Fagerli, UM, Brown, Peter De Nully, Boye Hansen, P, Mariz, JM, Jankovska, M, Walewski, J, Doorduijn, J, van Hoof, A, Christiansen, Ilse, Jyrkkiö, S, Kluin-Nelemans, JC, van Marwijk Kooy, M, Fijnheer, R, Stevens, W, Zijlstra, J, Böhmer, L, Lugtenburg, PJ, Grube, M, Prochazka, V, Salek, D, Greil, R, Trümper, L, Wulf, G, Altmann, B, Ziepert, M, Loeffler, M, Jantunen, E, Hopfinger, G, Van den Neste, E, Toldbod, H
Publikováno v:
D'Amore, F A, Gomes da Silva, M, Leppa, S, Relander, T, Pezzutto, A, Lauritzsen, GF, Weidmann, E, Van Gelder, M, Merup, M, Hagberg, H, Fagerli, UM, Brown, P D N, Boye Hansen, P, Mariz, JM, Jankovska, M, Walewski, J, Doorduijn, J, van Hoof, A, Christiansen, I, Jyrkkiö, S, Kluin-Nelemans, JC, van Marwijk Kooy, M, Fijnheer, R, Stevens, W, Zijlstra, J, Böhmer, L, Lugtenburg, PJ, Grube, M, Prochazka, V, Salek, D, Greil, R, Trümper, L, Wulf, G, Altmann, B, Ziepert, M, Loeffler, M, Jantunen, E, Hopfinger, G, Van den Neste, E & Toldbod, H 2011, ' First interim safety analysis of a phase III randomized trial in a newly diagnosed systemic peripheral T-cell lymphoma trated with CHOP chemotherapy with or without alemtuzumab and consolidated by autologous hematopoietic stem cell transplant. ', Blood, vol. 118, pp. 4110 .
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pure_au_____::8c75237e0e4c9149da84196165875359
https://pure.au.dk/portal/da/publications/first-interim-safety-analysis-of-a-phase-iii-randomized-trial-in-a-newly-diagnosed-systemic-peripheral-tcell-lymphoma-trated-with-chop-chemotherapy-with-or-without-alemtuzumab-and-consolidated-by-autologous-hematopoietic-stem-cell-transplant(afd7fe71-ecc7-4983-ba7e-d80804f0fb16).html
https://pure.au.dk/portal/da/publications/first-interim-safety-analysis-of-a-phase-iii-randomized-trial-in-a-newly-diagnosed-systemic-peripheral-tcell-lymphoma-trated-with-chop-chemotherapy-with-or-without-alemtuzumab-and-consolidated-by-autologous-hematopoietic-stem-cell-transplant(afd7fe71-ecc7-4983-ba7e-d80804f0fb16).html
Autor:
Lauritzsen, GF, Relander, T, Jantunen, E, Hagberg, H, Anderson, H, Merup, M, Brown, P, Østenstad, B, Kuittinen, O, Erlanson, M, Fagerli, UM, Delabie, J, Sundström, C, Ralfkiaer, E, Vornanen, M, D'Amore, Francesco Annibale
Publikováno v:
Lauritzsen, GF, Relander, T, Jantunen, E, Hagberg, H, Anderson, H, Merup, M, Brown, P, Østenstad, B, Kuittinen, O, Erlanson, M, Fagerli, UM, Delabie, J, Sundström, C, Ralfkiaer, E, Vornanen, M & D'Amore, F A 2011, ' CHOEP-14 and autologous stem cell tranplantation (ASCT) in angioimmunoblastic T-cell lymphoma: a prospective study by the Nordic Lymphoma Group (NLG-T-01) ', Annals of Oncology, vol. 22, no. 4, pp. 128 .
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pure_au_____::01825a24bc11456e60df8e20a4a8bb3d
https://pure.au.dk/portal/da/publications/choep14-and-autologous-stem-cell-tranplantation-asct-in-angioimmunoblastic-tcell-lymphoma-a-prospective-study-by-the-nordic-lymphoma-group-nlgt01(5d779b74-4c1a-4574-be08-4dbc94823657).html
https://pure.au.dk/portal/da/publications/choep14-and-autologous-stem-cell-tranplantation-asct-in-angioimmunoblastic-tcell-lymphoma-a-prospective-study-by-the-nordic-lymphoma-group-nlgt01(5d779b74-4c1a-4574-be08-4dbc94823657).html
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Publikováno v:
The Lancet; 1998, Vol. 352 Issue: 9127 p540-540, 1p
Autor:
Dahl AA; National Advisory Unit for Late Effects after Cancer Therapy, Oslo University Hospital, Oslo, Norway. alvandreas@msn.com., Smeland KB; National Advisory Unit for Late Effects after Cancer Therapy, Oslo University Hospital, Oslo, Norway; Department of Oncology, Oslo University Hospital, Oslo, Norway., Eikeland S; National Advisory Unit for Late Effects after Cancer Therapy, Oslo University Hospital, Oslo, Norway; Department of Oncology, Oslo University Hospital, Oslo, Norway., Fagerli UM; Department of Oncology, St Olav's Hospital, Trondheim, Norway; Institute of Clinical and Molecular Medicine, NTNU, Trondheim, Norway., Bersvendsen HS; Department of Oncology, University Hospital of Northern Norway, Tromsø, Norway., Fosså A; Department of Oncology, Oslo University Hospital, Oslo, Norway; KG Jebsen Centre for B-cell malignancies, University of Oslo, Oslo, Norway., Kiserud CE; National Advisory Unit for Late Effects after Cancer Therapy, Oslo University Hospital, Oslo, Norway; Department of Oncology, Oslo University Hospital, Oslo, Norway.
Publikováno v:
Acta oncologica (Stockholm, Sweden) [Acta Oncol] 2024 Aug 04; Vol. 63, pp. 600-606. Date of Electronic Publication: 2024 Aug 04.
Autor:
Pulczynski EJ; Department of Haematology, Aarhus University Hospital, Aarhus, Denmark; Department of Haematology, Region Hospital Goedstrup, Herning., Simonsen MR; Department of Hematology, Clinical Cancer Research Center, Aalborg University Hospital, Aalborg, Denmark; Department of Mathematical Sciences, Aalborg University, Aalborg., Kuittinen O; Department of Oncology, Kuopio University Hospital Cancer Center, Kuopio, Finland; Faculty of Medicine, Institute of Clinical Medicine, University of Eastern Finland, Kuopio., Fagerli UM; Department of Oncology, St Olav University Hospital, Trondheim, Norway; Department of Clinical and Molecular Medicine, Norwegian University of science and technology (NTNU), Trondheim, Norway., Erlanson M; Department of Radiation Sciences, Umeå University, Umeå, Sweden., Fluge Ø; Department of Oncology and Medical Physics, Haukeland University Hospital, Bergen, Norway., Leppä S; Research Programs Unit/Applied Tumor Genomics Research Program, University of Helsinki, Helsinki, Finland; Department of Oncology, Helsinki University Hospital Comprehensive Cancer Center, Helsinki., Østenstad B; Department of Oncology, Oslo University Hospital, Oslo, Norway., Fosså A; Department of Oncology, Oslo University Hospital, Oslo, Norway; KG Jebsen Centre for B-cell Malignancies, University of Oslo, Oslo, Norway., Eriksson M; Department of Oncology, Skane University Hospital, Lund, Sweden; Medical Oncology, Lund University, Lund, Sweden., El-Galaly T; Department of Hematology, Aalborg University Hospital, Aalborg., Kuitunen H; Cancer Centre, Oulu University Hospital, Oulu., Papworth K; Department of Radiation Sciences, Umeå University, Umeå, Sweden., Ljungqvist M; Department of Clinical Science and Education, Södersjukhuste, Karolinska Insitutet, Stockholm, Sweden; Haematology Centre, Karolinska University Hospital, Stockholm, Sweden., Pedersen MB; Department of Haematology, Aarhus University Hospital, Aarhus., Pollari M; Research Programs Unit/Applied Tumor Genomics Research Program, University of Helsinki, Helsinki, Finland; Department of Oncology, Tays Cancer Center, Tampere University Hospital, Tampere. marjukka.pollari@pirha.fi.
Publikováno v:
Haematologica [Haematologica] 2024 Jul 01; Vol. 109 (7), pp. 2359-2363. Date of Electronic Publication: 2024 Jul 01.
Autor:
Lia K; Vestre Viken, Bærum Hospital, Department of Oncology, Gjettum, Norway; Faculty of Medicine, University of Oslo. kjerli@vestreviken.no., Jørgensen RRK; Clinical Cancer Research Centre, Aalborg University Hospital, Department of Hematology, Denmark; Aalborg University, Department of Clinical Medicine, Denmark., L Wold B; Oslo University Hospital, Department of Oncology., Fluge Ø; Haukeland University Hospital, Department of Oncology, Bergen., Fagerli UM; St. Olavs Hospital, Department of Oncology, Trondheim., Bersvendsen H; University Hospital of North Norway, Department of Oncology, Tromsø., Bø IB; Stavanger University Hospital, Department of Hematology., Bhargava S; Cancer Registry of Norway, Majorstuen, Oslo, Norway; Akershus University Hospital, Department of Oncology, Lørenskog., Fosså A; Oslo University Hospital, Department of Oncology, Norway; KG Jebsen Centre for B-cell Malignancies, University of Oslo, Oslo.
Publikováno v:
Haematologica [Haematologica] 2024 May 01; Vol. 109 (5), pp. 1403-1412. Date of Electronic Publication: 2024 May 01.
Autor:
Husby T; Department of Circulation and Medical Imaging, Faculty of Medicine and Health Sciences, Norwegian University of Science and Technology, Postboks 8905, Trondheim, Norway.; Department of Oncology, St. Olavs Hospital, Trondheim University Hospital, Trondheim, Norway., Johannessen K; Department of Circulation and Medical Imaging, Faculty of Medicine and Health Sciences, Norwegian University of Science and Technology, Postboks 8905, Trondheim, Norway., Berntsen EM; Department of Circulation and Medical Imaging, Faculty of Medicine and Health Sciences, Norwegian University of Science and Technology, Postboks 8905, Trondheim, Norway.; Department of Radiology and Nuclear Medicine, St. Olavs Hospital, Trondheim University Hospital, Trondheim, Norway., Johansen H; Department of Radiology and Nuclear Medicine, St. Olavs Hospital, Trondheim University Hospital, Trondheim, Norway., Giskeødegård GF; Department of Public Health and Nursing, Faculty of Medicine and Health Sciences, Norwegian University of Science and Technology, Trondheim, Norway., Karlberg A; Department of Circulation and Medical Imaging, Faculty of Medicine and Health Sciences, Norwegian University of Science and Technology, Postboks 8905, Trondheim, Norway.; Department of Radiology and Nuclear Medicine, St. Olavs Hospital, Trondheim University Hospital, Trondheim, Norway., Fagerli UM; Department of Oncology, St. Olavs Hospital, Trondheim University Hospital, Trondheim, Norway.; Department of Clinical and Molecular Medicine, Faculty of Medicine and Health Sciences, Norwegian University of Science and Technology, Trondheim, Norway., Eikenes L; Department of Circulation and Medical Imaging, Faculty of Medicine and Health Sciences, Norwegian University of Science and Technology, Postboks 8905, Trondheim, Norway. live.eikenes@ntnu.no.
Publikováno v:
EJNMMI reports [EJNMMI Rep] 2024 Jan 31; Vol. 8 (1), pp. 2. Date of Electronic Publication: 2024 Jan 31.
Autor:
Dahl AA; National Advisory Unit for Late Effects after Cancer Therapy, Oslo University Hospital, Oslo, Norway. alvdah@ous-hf.no.; Department of Oncology, Oslo University Hospital, Oslo, Norway. alvdah@ous-hf.no., Smeland KB; National Advisory Unit for Late Effects after Cancer Therapy, Oslo University Hospital, Oslo, Norway.; Department of Oncology, Oslo University Hospital, Oslo, Norway., Eikeland S; National Advisory Unit for Late Effects after Cancer Therapy, Oslo University Hospital, Oslo, Norway.; Department of Oncology, Oslo University Hospital, Oslo, Norway., Fagerli UM; Department of Oncology, St Olav's Hospital, Trondheim, Norway., Bersvendsen HS; Department of Oncology, University Hospital of Northern Norway, Tromsø, Norway., Fosså A; Department of Oncology, Oslo University Hospital, Oslo, Norway.; KG Jebsen Center for B-Cell Malignancies, University of Oslo, Oslo, Norway., Kiserud CE; National Advisory Unit for Late Effects after Cancer Therapy, Oslo University Hospital, Oslo, Norway.; Department of Oncology, Oslo University Hospital, Oslo, Norway.
Publikováno v:
Journal of cancer survivorship : research and practice [J Cancer Surviv] 2023 Aug 01. Date of Electronic Publication: 2023 Aug 01.